FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAnatara Lifesciences Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
ANR.AX
Anatara Lifesciences Ltd Stock AnalysisComprehensive stock analysis for Anatara Lifesciences Ltd (ANR.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisANR.AX
ANR.AX
Anatara Lifesciences Ltd
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Discussion
ANR.AX
  1. Home
  2. Stocks
  3. Anatara Lifesciences Ltd

Anatara Lifesciences Ltd

🇦🇺ANR.AX•ASX

Anatara Lifesciences Ltd

🇦🇺ANR.AX•ASX

Your view on ANR.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Anatara Lifesciences Ltd

Industry
Biotechnology
Sector
Healthcare
CEO
David Lionel Brookes
Headquarters
62 Lygon Street, Adelaide, SA, AU
Industry
Biotechnology
Sector
Healthcare
CEO
David Lionel Brookes
Headquarters
62 Lygon Street, Adelaide, SA, AU
Description

Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals.

Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease.

The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water.

This company was founded in 2010 and is headquartered in Carlton, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Anatara Lifesciences Ltd. Starting points for Anatara Lifesciences Ltd: beta 0.70 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Anatara Lifesciences Ltd. Anatara Lifesciences Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Anatara Lifesciences Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 20, 2026
More →

Earnings per share estimates

Per shareThis quarterJun 2016Next quarterJun 2017This yearYear to Jun 2016Next yearYear to Jun 2017
Average estimate−AUD 0.03−AUD 0.05−AUD 0.02−AUD 0.04
Lowest estimate−AUD 0.03−AUD 0.05−AUD 0.02−AUD 0.04
Highest estimate−AUD 0.02−AUD 0.04−AUD 0.02−AUD 0.04
Number of analysts2311
A year ago————
Growth vs a year ago————

Revenue estimates

TotalThis quarterJun 2016Next quarterJun 2017This yearYear to Jun 2016Next yearYear to Jun 2017
Average estimateAUD 1.18MAUD 1.79MAUD 1.00MAUD 1.75M
Lowest estimateAUD 1.13MAUD 970000.00AUD 1.00MAUD 1.75M
Highest estimateAUD 1.19MAUD 2.58MAUD 1.00MAUD 1.75M
Number of analysts2311
A year ago————
Growth vs a year ago————

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Anatara Lifesciences Ltd. Anatara Lifesciences Ltd has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ANR.AX20 companies
Compare ANR.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
1AD.AXAdAlta LimitedHealthcareBiotechnology—
ACR.AXAcrux LimitedHealthcareBiotechnology—
BIT.AXBiotron LimitedHealthcareBiotechnology—
CTQ.AXCareteq LimitedHealthcareMedical - Healthcare Information Services—
EXL.AXElixinol Wellness LimitedHealthcareDrug Manufacturers - Specialty & Generic—
IBX.AXImagion Biosystems LimitedHealthcareMedical - Diagnostics & Research—
OAK.AXOakridge International LimitedHealthcareMedical - Healthcare Information Services—
OSX.AXOsteopore LimitedHealthcareMedical - Instruments & Supplies—
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
PRTCYPureTech Health plcHealthcareOTC—
PRVCFPreveCeutical Medical Inc.HealthcareOTC$10.1M
PSYBFPsyBio Therapeutics Corp.HealthcareOTC$1,275
PTCHFPureTech Health plcHealthcareOTC$410.4M
PTCTPTC Therapeutics, Inc.HealthcareNASDAQ$5.0B
PTGXProtagonist Therapeutics, Inc.HealthcareNASDAQ$8.3B
PTHSPelthos Therapeutics Inc.HealthcareAMEX$27.9M
PTIXProtagenic Therapeutics, Inc.HealthcareNASDAQ$470,654
PTNPalatin Technologies, Inc.HealthcareNASDAQ$9.2M
PTX.AXPrescient Therapeutics LimitedHealthcareASX—
PULMPulmatrix, Inc.HealthcareNASDAQ$4.9M
PVCTProvectus Biopharmaceuticals, Inc.HealthcareOTC$18.7M
Open Comparable Analysis
Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Anatara Lifesciences Ltd.

ANR.AX AnalysisFair
Past
1
Growth
2
Health
5
Profit
1
Value
1